The DNDN LONGS ARE EVEN MORE SHORT SIGHTED WHEN THEY MAKE THREATS AGAINST PEOPLE WILLING TO LOOK AT THE DATA.
Biowatch - You are one of the few posters who usually offers a balanced and informative view unlike the biased posts of some well-known posters here. However, your blanket statement above about all "The DNDN LONGS" is not just uncalled for, it is likely incorrect. Let's not forget that the extreme views posted here and other boards, positive or negative, are at most from just a minority few who spend all their waking time on these investment boards. Some of these people are clearly in arrested development but sadly too vocal.
The FDA did NOT say NO, they said give us more data. Big difference.
This statement does not take into account the short time to live that some PC patients do not have to wait for new data. As the ABC news piece tonight showed, the true disappointment in the FDA decision is from many PC patients who have been deprived of the ability to try, apparently at little risk, a treatment with fairly strong evidence of efficacy, even if that still seemed inadequate to some.
